SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Dov Pharmaceutical, Inc - DOVP -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (140)4/25/2006 7:52:53 AM
From: rkrw  Respond to of 172
 
dovp royalties were one of the few where it was fully disclosed. So I can remember that :-)

No question nbix would like to get their hands on the dovp royalties, if they could, in a non dilutive way, i.e. cash. Tack on another 10% or more to what pfe would pay them in a buyout :-) But who can say if dovp is ready to give up?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News